chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Accelerated heart rate of 135-150bpm; fatigue/tiredness; This is a spontaneous report from a Pfizer-sponsored program received from a contactable consumer (patient's mother). A 16-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 16May2021 (Batch/Lot number was not reported) as 2nd dose, single dose for COVID-19 immunization. Patient received the first dose of bnt162b2 on 25Apr2021. The patient's medical history and concomitant  medications were not reported. After receiving the second dose, the following day on 17May2021, patient experienced an accelerated heart rate of 135-150 bpm. Her resting pulse is 80 bpm. Patient also experienced fatigue and tiredness. Outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This case was reported by a consumer via call center representative and described the occurrence of fever in a 51-year-old male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fever and chills. On an unknown date, the outcome of the fever was resolved with sequelae and the outcome of the chills was recovering/resolving. It was unknown if the reporter considered the fever and chills to be related to SHINGRIX. Additional details were provided as follows: The reporter was a contractor for GlaxoSmithKline and she works in research. The age at vaccination was not reported. The pharmacist told her that he had chills and fever when he had the first dose of SHINGRIX about a year before the date of reporting in 2018. The patient received the 2nd dose of SHINGRIX but reported side effects with the 1st dose. The reporter did not have any additional details on this report. The reporter heard about this at time of reporting. This case has been linked to the case US2019027654, reported by the same reporter.
I noticed there is a lot of red liquid in that round little circle.; This is a spontaneous report from a contactable consumer (patient) and Pfizer-sponsored program. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration in Arm on 10Mar2021 (Batch/Lot number was not reported, expiry date: unknown) as dose 1, single for covid-19 immunization. The medical history and concomitant medications were not reported. The patient stated when she came home, she was looking at her arm and she still had that little square bandage that the gentleman put on her arm. But in the middle, there was a clear plastic circle and she noticed there was a lot of red liquid in that round little circle. The outcome of event was unknown.  Information on lot/batch number has been requested.
Patient awoke from sleep with "Tingling" in all 4 extremities as well as his lower face/Jaw. Symptoms became worse over several hours and he phoned me his PCP who referred him to local ER. Patient developed shortness of breath on arrival to the ER (approximately 8am local time have diffuse wheezing and given 20 mg of oral prednisone. Chest xray, cardiac enzymes and CBC were relatively unremarkable with the exception of his differential showing 8 eosinophils. His symptoms resolved and he was discharged home on oral steroids and has followed up with me virtually. While having adult onset asthma with periodic exacerbations requiring steroids, the patient has never had any numbness or tingling and given the vaccination earlier in the day, the presence of eosinophils on his differential and the rapid resolution of his symptoms with steroids, the event is being reported after the Emergency Department MD refused to report the event
a 56 y.o. female with a history of nausea, vomiting, diarrhea. Started getting sick about 4 days ago, tested + for COVID then. Started getting short of breath a couple days ago related to above, worse with exertion, nothing makes it better. Fever and chills with this. To ED, has PE on CVA."   Hospital Course:  The patient was admitted to the hospital and was evaluated and treated per below.      * Pulmonary embolism associated with COVID-19 o Pulmonary embolism associated with covid-19 virus. Continue to monitor on telemetry. Echocardiogram showed no right heart strain. Treated initially with IV heparin drip transitioned to PO Eliquis with continued improvement. Continue to monitor closely. Discharged home on oral anticoagulation to follow up outpatient with primary care provider. o Pneumonia due to Covid 19 virus with acute respiratory failure with hypoxia. Improving on current treatment. Continue Remdesivir D3/5. Nebs and inhalers as ordered. Continue to follow up daily inflammatory markers and d-dimer. Patient was Weaned off oxygen to RA. Continue nebs and inhalers. Encourage incentive spirometry use and pronating. Continue supportive/symptomatic treatment and supplements as ordered per COVID protocol. Followed up daily lab. Home oxygen to use as needed. o Diabetes mellitus type 2. Continue with same home regimen/equivalent. Monitor blood sugar and cover with insulin sliding scale. Advance diet to a diabetic. A1c ordered. o Hypertension. Controlled. Continue same treatment. Follow up daily labs.
Pt with stuffy nose and cough for 3 day since H1N1 nasal spray 10/9/09. Low grade fevers 10/12/09. Called back at 11 a.m. 10/12/09 and pt developed hives. 10/12/09 had temp 101.6 and swelling in face-temp got as high as 105. Seen in office 10/13/09 without resolving sx. without PREDNISONE.
Continuous pain in the arm of the injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Continuous pain in the arm of the injection) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Continuous pain in the arm of the injection). At the time of the report, PAIN IN EXTREMITY (Continuous pain in the arm of the injection) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: over 170 (High) over 170.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported.  No Treatment information was reported.
Cannot walk yet without walker; This spontaneous case was received on 27-Jul-2021 from other non-health professional via Sanofi Pasteur (reference numbers 2021SA208806 and US-SA-SAC20210623001028) with additional information (being processed together) received on the same day via Med Communications (reference number: SEQW21-01516) and concerned a male patient of an unknown age. At the time of initial reporting, the patient was a 76-year-old.  The patient's medical history and concomitant medications were not reported.  On an unspecified date, the patient was vaccinated with Fluvirin (influenza virus vaccine polyvalent; dose, anatomical location, route of administration: not reported) as a prophylactic vaccination. The batch number was not reported.  On an unspecified date, the patient was vaccinated with non-company, co-suspect vaccine Fluzone High Dose (Influenza vaccine inact split 3v; dose, anatomical location, route of administration: not reported) as a prophylactic vaccination. The batch number was not reported.  On an unspecified date, the patient was vaccinated with non-company, co-suspect vaccine Zostavax (varicella zoster vaccine live (Oka/Merck); dose, anatomical location, route of administration: not reported) as a prophylactic vaccination. The batch number was not reported.  On an unspecified date, unknown amount of time after receiving Fluvirin and non-company, co-suspects Zostavax and Fluzone High Dose, the patient could not walk without walker. Details of laboratory data were not reported. It was not reported if the patient received a corrective treatment.  The outcome of the event was unknown.  The reporter did not provide a causality assessment.  The event of 'walking difficulty' was assessed as serious due to criteria of disability and medically significance.  Company comment: An elderly male patient was vaccinated with suspect Fluvirin vaccine and non-company co-suspect vaccines Fluzone High Dose and Zostavax. An unknown amount of time after vaccination the patient could not walk without walker. There is a lack of information regarding vaccination dates and event onset date, therefore chronology needs more clarification. Information regarding the underlying medical history, related diagnostic findings and concomitant medications have not been provided. Due to limited information, causality for the reported event is unassessable.; Sender's Comments: An elderly male patient was vaccinated with suspect Fluvirin vaccine and non-company co-suspect vaccines Fluzone High Dose and Zostavax. An unknown amount of time after vaccination the patient could not walk without walker. There is a lack of information regarding vaccination dates and event onset date, therefore chronology needs more clarification. Information regarding the underlying medical history, related diagnostic findings and concomitant medications have not been provided. Due to limited information, causality for the reported event is unassessable.
3 days of fever; extensive body aches; fatigue; injection site swelling and soreness; injection site swelling and soreness; redness- size of a lemon. Redness lasted 7 days; could not lift arm w/o discomfort for 7 days; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 74-year-old female patient (not pregnant) received pneumococcal 20-val conj vac (dipht crm197 protein) (PREVNAR 20), on 12Oct2023 at 10:00 as dose 1, single (Batch/Lot number: unknown) at the age of 74 years, in right deltoid for immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Dtap (although DTap Booster in Aug2013 had adverse effect, as if my brain was on LSD. Filed a CDC report at that time. Will NOT get another.), administration date: Aug2013, for immunization, reaction(s): "brain was on LSD". The following information was reported: PYREXIA (non-serious) with onset 12Oct2023 at 18:00, outcome "recovered with sequelae" (23Oct2023), described as "3 days of fever"; LIMB DISCOMFORT (non-serious) with onset 12Oct2023 at 18:00, outcome "recovered with sequelae" (23Oct2023), described as "could not lift arm w/o discomfort for 7 days"; PAIN (non-serious) with onset 12Oct2023 at 18:00, outcome "recovered with sequelae" (23Oct2023), described as "extensive body aches"; FATIGUE (non-serious) with onset 12Oct2023 at 18:00, outcome "recovered with sequelae" (23Oct2023); VACCINATION SITE PAIN (non-serious), VACCINATION SITE SWELLING (non-serious) all with onset 12Oct2023 at 18:00, outcome "recovered with sequelae" (23Oct2023) and all described as "injection site swelling and soreness"; VACCINATION SITE ERYTHEMA (non-serious) with onset 12Oct2023 at 18:00, outcome "recovered with sequelae" (23Oct2023), described as "redness- size of a lemon. Redness lasted 7 days". Therapeutic measures were not taken as a result of pyrexia, pain, fatigue, vaccination site pain, vaccination site swelling, vaccination site erythema, limb discomfort. Additional information: The patient had no known allergies. Vaccine was administered at doctor's office/urgent care. The redness lasted 7 days, soreness too, and could not lift arm w/o discomfort for 7 days. As reported, the patient recovered with lasting effects for all events.  The information on the batch/lot number for pneumococcal 20-val conj vac (dipht crm197 protein), pneumococcal 20-val conj vac (dipht crm197 protein)  has been requested and will be submitted if and when received.
Patient developed a rash on her feet and ankles at night on 2/24/16. No treatment used.
Patient came to the Immunization clinic and told me that she had  left sided facial droop 3 days after receiving her shingles 2nd dose and was treated in  the Emergency Room.  Patient wanted me to submit this report. She would know all details since this happened about 2 years ago
Fever, chills, body aches, muscle aches, skin rash, headache, soreness
At noon, 10/31, I received the PNEUMOVAX 23 and Flu Vaccine Shots at the same time. From 6 pm to 8 pm, I worked out with weights and jogged 7 miles on the treadmill. After returning home and within ten minutes of completing the work-out, I experienced an episode of severe chills, then fever which broke while sleeping with profuse sweating by 3:00 am. Afterwards, I felt fine, but upon working out again the next day, I experienced a similar episode of chills/fever although of much less severity. This continued for day 3 and then reached baseline by day 4. The intensity of the chills/fever was 8/10 on day 1; 3/10 on day 2; 1/10 on day 3. In addition, it is unclear that I needed the PNEUMOVAX 23 vaccine in the first place. I am 55, male, and am in excellent health. The patient information for PNEUMOVAX 23 available from Merck at their website indicates that the vaccine should be used for those aged 50 and older; in addition, there are places on the website for Merck PNEUMOVAX 23 that indicates that the vaccine should be used for those 50 and older. However, contrary to this recommendation, the Merck website and the prescribing information indicates that it should be used for people aged 65 and older, and that for those 50 and older who have certain conditions. Merck should clarify this inconsistency in regard to the age group 50 - 64: one publication implies that all 50-64, should take it; and the other publication indicates that only those with specialized conditions in the age bracket 50-64, should take it. Since, although I am 55, I do not have those specialized conditions, and therefore believe that I should not have taken PNEUMOVAX 23.
strong arm pain and fever between 99.9 and 101.6 for about 2 days
Pt. states that after receiving the 3rd dose of Phizer 12/29/2021, started experiencing symptoms 15mins later of extreme arm pain throughout the Left arm and middle of the back. No noted Primary visit/communications. Still continuing to experience symptoms.
Pt says she developed a case of shingles after receiving the ZOSTAVAX injection. A rash developed. She went to her doctor who prescribed acyclovir 5% topical.
Guillian Barre Synd, onset of myalgia about 2 wks /p vax, increased weakness of extremities, legs > arms & in legs prox? distal musculature. Hospitalized 11Dec90
On 09/15/2022 I received my Covid-19 vaccine. On 11/25/2022 I was experiencing stomach issue diarrhea, nausea that progressively gotten worst. I reached out to my health care provider I had a Cat scan with contrast that showed EPI. I was prescribed ZENPEP. Symptoms are ongoing.
Non-itchy rash on neck, trunk, arms and legs, starting on 2/9/01. Reported from pt's mother on 2/16/01. States she hasn't noticed the rash since 2/14/01.
Pt died on 1/9/22. Pt remained critically ill throughout hospital stay  and became bradycardic then asystolic on 1/9.  ACLS was provided x 2.  ROSC achieved x 2, then 3rd time patient was not able to regain ROSC.
Day 1 - increasingly tired - couldn't drive home after work, slight nausea, aching muscles entire body. Day 2 - all above plus fever-like symptoms (chills, sweating, nightmares), loss of appetite but no fever. Day 3 - all above plus frequent urination, feeling really ill - more sick than I have ever felt in my adult life (not since I had mono as a child). Day 4 to Day 21 - feeling weak, unmotivated, lethargic, depressed, muscle pain (especially in legs) off and on. Day 22 - 25 unusually tired, increasing pain in muscles of legs to the point of being almost unable to walk. Day 26 (Christmas) - still unusually tired, muscle pains plus feeling nauseous, loss of appetite, feverish achiness, chills, sweats, restlessness, unable to sleep but no fever at all once again, and nightmares--feeling more sick than I ever have in my adult life (not since mono as a child). Day 27 - same as Day 26 - feeling better in mornings - fitful feverish sleep in the afternoon with difficulty waking no fever. Day 28 - Day 30 (today) - same as above, with mucus and sneezing starting and on Day 30 some head and lung congestion.
Extremely sore arm  Chills Fever 102  Extreme muscle pain and fatigue Headache
Patient experienced, redness, swelling and heat to injection site, advised to use heat to affected area, offered antibiotic but patient refused.
When asked, patient stated she had gotten the Pfizer vaccine for the first dose. Afterwards the vaccine card showed she had gotten the Moderna a month ago in another facility.
Started night of immunization with rash, abdominal pain, nausea and vomiting. Had a fever up to 102F, over the weekend but much better now, at times is 100F. Had muscle aches and joint pain but is better. Also, nausea and vomiting is better. No treatment.
Approximately 12 vaccine administered. 6:50 patient presented with heavy chest/coughing/tingling mouth/swollen tongue/headache/itchy eyes.
Information has been received from a nurse concerning a female who was vaccinated with a dose of Gardasil.  Subsequently the patient developed soreness in her arm.  At the time of the report the patient's outcome was unknown.  Additional information has been requested.
Sore throat. At 9pm itchy eyes. On 9/24 morning red itchy eyes. Muscles ached badly until 9/28; painful to bend. No medication taken.
Pt reported that she went home and vomitted 5 times & felt chest pain on side of vaccine.  However it later subsided.  Requested to be reported.  confirmed on 11/2/21 that she is doing better.  No longer experiencing symptoms
Dizziness when she gets up; she was not feeling well; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness when she gets up) and MALAISE (she was not feeling well) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     Concurrent medical conditions included Vertigo. Concomitant products included MECLIZINE HCL for an unknown indication.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness when she gets up) and MALAISE (she was not feeling well). At the time of the report, DIZZINESS (Dizziness when she gets up) and MALAISE (she was not feeling well) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Significant Follow up
fever, dehydration, excessive mucous production, chills, no appetite, shortness of breath, weight loss, and fatigue  Narrative:
Flushing, tingling of hands, gum, tongue, fainting.  She took a Benadryl on her arm.  She got a flu shot yearly but has never received a pneumo shot.  Onset happened within 5 minutes of pneumo shot.
low grade fever; lump in the arm underneath skin; body aches and pains; chills; This is a spontaneous report from a contactable consumer (patient). A 43-year-old male patient received bnt162b2 (reported as COVID 19 vaccine), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced Low graded fever, Lump in arm underneath Skin, Body aches and pain, Chills on an unspecified date. He was concerned because it was still going on. The outcome of events was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Headache body aches in upper back, bilateral knee pain, weakness, fatigue Narrative:
Patient states throat felt "thick." No trouble breathing at all but the thick feeling persisted.  Also felt lightheaded, dizzy, and weak.
Arms sore; Initial information received on 26-Oct-2021 regarding an unsolicited valid non-serious case from a Social Media via a consumer/non-health care professional.  This case involves a patient (unknown demographics) who had arms sore (vaccination site pain) after receiving INFLUENZA VACCINE and corona virus diseases of 2019 (COVID-19) VACCINE MRNA (MRNA 1273) (MODERNA COVID-19 VACCINE).  It was unknown if the patient had any medical history, concomitant disease or risk factor.  The patient's past medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry not reported) via unknown route in the arm Not Otherwise Specified (NOS) for prophylactic vaccination.  On an unknown date, the patient received a dose of suspect MODERNA COVID-19 VACCINE (booster) not produced by Sanofi Pasteur (batch number and expiry not reported) via unknown route in the arm NOS for prophylactic vaccination.  On an unknown date the patient developed a non-serious arms sore (vaccination site pain) (unknown latency) following the administration of INFLUENZA VACCINE and MODERNA COVID-19 VACCINE.  It was reported "Got my flu shot in one arm and my Moderna booster in the other on Sunday! Makes both arms sore as hell worth it"  It was unknown if the patient experienced any additional symptoms/events.  There were no lab data/results available.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, outcome of the event was unknown.  The reporter did not report the causality of event with suspects.  There will be no information available on the batch number for this case.
Patient received a Pfizer BioNTech Adolescent/Adult Vaccine (Lot# 301458A) that was stored in the regular freezer (-25 to  -15 oC) beyond 14 days. On 22JAN22 Pfizer responded to and that stability data does not support the use of the Pfizer Vaccine (Lot# 301458A). Pfizer further states decision to release or dispose of the product is the responsibility of Agency. The  website states that if the manufacturer does not have the information to support the stability of the vaccine, repeat the dose immediately with no minimum interval.
muscle ache with "spasm" like feeling @ injection site.  Zero redness.  Zero swelling.  Advised alternating warm/cold compress with IBUPROFEN.  Call after 1 week if zero better.
bad rash on arm at site of shot at first, one inch by two inches now three inches by five inches
immed p/vax devel red area around inject site 5cm x 5cm w/o hive formation; given DPH 15-20 mins later redness gone; can't eat whole cooked egg (hives) but no problem w/egg cooked in pancake, french toast, swallow drink w/raw eggs;
Recent was diagnosed with pneumonia through a local urgent care. During the diagnosis, a chest X-ray was performed and a mass in my right lung was discovered. Pneumonia has been treated with antibiotics.
Redness, swelling, warm to touch, itching.  Pt given loratadine 10 mg on 08/17/2011 to help with reaction.